ZFY
gene geneOn this page
Also known as ZNF911
Summary
ZFY (zinc finger protein Y-linked, HGNC:12870) is a protein-coding gene on chromosome Yp11.2, encoding Zinc finger Y-chromosomal protein (P08048). Probable transcriptional activator.
This gene encodes a zinc finger-containing protein that may function as a transcription factor. This gene was once a candidate gene for the testis-determining factor (TDF) and was erroneously referred to as TDF.
Source: NCBI Gene 7544 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 46 total
- MANE Select transcript:
NM_003411
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12870 |
| Approved symbol | ZFY |
| Name | zinc finger protein Y-linked |
| Location | Yp11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZNF911 |
| Ensembl gene | ENSG00000067646 |
| Ensembl biotype | protein_coding |
| OMIM | 490000 |
| Entrez | 7544 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 7 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000155093, ENST00000383052, ENST00000443793, ENST00000449237, ENST00000469869, ENST00000478783, ENST00000625061, ENST00000890804, ENST00000963502
RefSeq mRNA: 12 — MANE Select: NM_003411
NM_001145275, NM_001145276, NM_001369702, NM_001369703, NM_001369704, NM_001369705, NM_001369706, NM_001369707, NM_001369708, NM_001369709, NM_001369710, NM_003411
CCDS: CCDS14774, CCDS48200, CCDS48201
Canonical transcript exons
ENST00000155093 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001648585 | 2935381 | 2935769 |
| ENSE00003764421 | 2975095 | 2975244 |
| ENSE00003768468 | 2975511 | 2975654 |
| ENSE00003889480 | 2953909 | 2953997 |
| ENSE00003889859 | 2976670 | 2976822 |
| ENSE00003891660 | 2977940 | 2978080 |
| ENSE00003895708 | 2978810 | 2982506 |
| ENSE00003895848 | 2961074 | 2961646 |
Expression profiles
Bgee: expression breadth ubiquitous, 224 present calls, max score 93.76.
FANTOM5 (CAGE): breadth broad, TPM avg 2.8356 / max 61.8116, expressed in 844 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201096 | 2.8356 | 844 |
Top tissues by expression
289 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 93.76 | gold quality |
| male germ cell | CL:0000015 | 89.98 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.57 | gold quality |
| rectum | UBERON:0001052 | 76.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.95 | gold quality |
| parietal pleura | UBERON:0002400 | 75.30 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 74.32 | gold quality |
| calcaneal tendon | UBERON:0003701 | 73.80 | gold quality |
| oral cavity | UBERON:0000167 | 73.58 | gold quality |
| adrenal tissue | UBERON:0018303 | 73.58 | gold quality |
| upper leg skin | UBERON:0004262 | 73.37 | gold quality |
| pleura | UBERON:0000977 | 72.89 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 72.82 | gold quality |
| right lung | UBERON:0002167 | 71.66 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 71.12 | gold quality |
| amniotic fluid | UBERON:0000173 | 70.80 | gold quality |
| cauda epididymis | UBERON:0004360 | 70.76 | gold quality |
| penis | UBERON:0000989 | 70.70 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 70.33 | gold quality |
| prostate gland | UBERON:0002367 | 70.31 | gold quality |
| ventricular zone | UBERON:0003053 | 70.22 | gold quality |
| testis | UBERON:0000473 | 70.14 | gold quality |
| endothelial cell | CL:0000115 | 70.11 | silver quality |
| corpus epididymis | UBERON:0004359 | 70.08 | gold quality |
| superficial temporal artery | UBERON:0001614 | 70.01 | gold quality |
| metanephros cortex | UBERON:0010533 | 69.66 | gold quality |
| visceral pleura | UBERON:0002401 | 69.45 | gold quality |
| left testis | UBERON:0004533 | 69.28 | gold quality |
| caput epididymis | UBERON:0004358 | 69.24 | gold quality |
| right testis | UBERON:0004534 | 69.07 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.66 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
116 targeting ZFY, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
Literature-anchored findings (GeneRIF, showing 2)
- Studies identified a major testis-specific ZFY transcript that encodes a protein with the same short acidic domain. (PMID:22407129)
- Characterization of the ZFX family of transcription factors that bind downstream of the start site of CpG island promoters. (PMID:32406922)
Cross-species orthologs
0 orthologs
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger Y-chromosomal protein — P08048 (reviewed: P08048)
All UniProt accessions (2): P08048, C9JQM1
UniProt curated annotations — full annotation on UniProt →
Function. Probable transcriptional activator. Binds to the consensus sequence 5’-AGGCCY-3'.
Subcellular location. Nucleus.
Domain organisation. The binding of ZFY to DNA is mediated by the interaction of the GGCC core base pairs with zinc fingers 12 and 13.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family. ZFX/ZFY subfamily.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P08048-1 | 1 | yes |
| P08048-2 | 2 | |
| P08048-3 | 3 |
RefSeq proteins (12): NP_001138747, NP_001138748, NP_001356631, NP_001356632, NP_001356633, NP_001356634, NP_001356635, NP_001356636, NP_001356637, NP_001356638, NP_001356639, NP_003402* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006794 | Transcrp_activ_Zfx/Zfy-dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF04704, PF13909
UniProt features (29 total): zinc finger region 13, sequence conflict 6, splice variant 5, strand 2, chain 1, modified residue 1, helix 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 1KLR | SOLUTION NMR | |
| 1KLS | SOLUTION NMR | |
| 1XRZ | SOLUTION NMR | |
| 5ZNF | SOLUTION NMR | |
| 7ZNF | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P08048-F1 | 54.23 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 270
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 127 (showing top):
GOBP_BEHAVIOR, CCAWYNNGAAR_UNKNOWN, XU_GH1_AUTOCRINE_TARGETS_UP, SP3_Q3, GOBP_GROWTH, GOBP_OOGENESIS, CREBP1_Q2, BROWNE_HCMV_INFECTION_16HR_UP, GOBP_MALE_GAMETE_GENERATION, BROWNE_HCMV_INFECTION_12HR_UP, YY1_Q6, GOBP_OVARIAN_FOLLICLE_DEVELOPMENT, GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT, YY1_02, GOBP_PARENTAL_BEHAVIOR
GO Biological Process (12): ovarian follicle development (GO:0001541), regulation of transcription by RNA polymerase II (GO:0006357), spermatogenesis (GO:0007283), fertilization (GO:0009566), post-embryonic development (GO:0009791), multicellular organism growth (GO:0035264), positive regulation of transcription by RNA polymerase II (GO:0045944), oocyte development (GO:0048599), homeostasis of number of cells (GO:0048872), parental behavior (GO:0060746), regulation of DNA-templated transcription (GO:0006355), germ cell development (GO:0007281)
GO Molecular Function (8): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (4): chromatin (GO:0000785), nucleus (GO:0005634), nucleoplasm (GO:0005654), nucleolus (GO:0005730)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| transcription by RNA polymerase II | 2 |
| developmental process involved in reproduction | 2 |
| multicellular organismal process | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| cellular anatomical structure | 2 |
| nuclear lumen | 2 |
| female gonad development | 1 |
| anatomical structure development | 1 |
| regulation of DNA-templated transcription | 1 |
| male gamete generation | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| multicellular organism development | 1 |
| developmental growth | 1 |
| positive regulation of DNA-templated transcription | 1 |
| germ cell development | 1 |
| oocyte differentiation | 1 |
| multicellular organismal-level homeostasis | 1 |
| reproductive behavior | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| gamete generation | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| cell development | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
764 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFY | SRY | Q05066 | 949 |
| ZFY | USP9Y | O00507 | 876 |
| ZFY | DDX3Y | O15523 | 876 |
| ZFY | KDM5D | Q9BY66 | 864 |
| ZFY | EIF1AY | O14602 | 836 |
| ZFY | UTY | O14607 | 794 |
| ZFY | RPS4Y1 | P22090 | 786 |
| ZFY | AMELY | Q99218 | 783 |
| ZFY | TMSB4Y | O14604 | 770 |
| ZFY | NLGN4Y | Q8NFZ3 | 752 |
| ZFY | TSPY1 | P09002 | 747 |
| ZFY | AMELX | Q99217 | 736 |
| ZFY | MEA1 | Q16626 | 716 |
| ZFY | ZPR1 | O75312 | 702 |
| ZFY | PRKY | O43930 | 681 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| L3MBTL2 | ZFY | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZFY | L3MBTL2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZFY | DMRT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFY | KAT14 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFY | psi-mi:“MI:0915”(physical association) | 0.370 | |
| CCL22 | ZFY | psi-mi:“MI:0915”(physical association) | 0.370 |
| IL31 | ZFY | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZFY | ZBTB9 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZFY | ZFX | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| L3MBTL2 | ZFY | psi-mi:“MI:0915”(physical association) | 0.000 |
| DMRT3 | ZFY | psi-mi:“MI:0915”(physical association) | 0.000 |
| KAT14 | ZFY | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): ZFY (Affinity Capture-MS), ZFX (Affinity Capture-MS), NSD1 (Affinity Capture-MS), CACNB3 (Affinity Capture-MS), ZFY (Two-hybrid), ZFY (Two-hybrid), L3MBTL2 (Two-hybrid), CSRP2BP (Two-hybrid), CACNB3 (Affinity Capture-MS), ZFX (Affinity Capture-MS), NSD1 (Affinity Capture-MS), ZFY (Proximity Label-MS), ZFY (Affinity Capture-MS), PPIB (Cross-Linking-MS (XL-MS)), ZFY (Affinity Capture-RNA)
ESM2 similar proteins: A1L1J6, A2ANX9, A7Y7X5, E9Q8T2, G5E8B9, O15060, O43167, O43829, O62836, O95625, P08048, P0C6P6, P10925, P17010, P17012, P20662, P52739, Q01611, Q08376, Q0VCB0, Q2FAY8, Q3TTC2, Q4V8R6, Q52V16, Q5DU09, Q5PPG4, Q5R5M1, Q5R5N5, Q5RAU9, Q5SVQ8, Q6B4Z5, Q6GNP2, Q6INV8, Q7TS63, Q7ZVR6, Q80V63, Q80X44, Q811F1, Q8K3J5, Q92010
Diamond homologs: A0A9P4XV22, A2ANX9, B1H2Q6, O62836, P08048, P0CJ78, P10925, P17010, P17012, P20662, P27705, P28698, P52288, P80944, Q01611, Q03081, Q03125, Q0VDT2, Q29419, Q3U3I9, Q52V16, Q567C6, Q5U2Z0, Q6B4Z5, Q7RTV3, Q95LI3, Q966L8, Q96EG3, Q9UDV6, Q9UL36, Q9Y462, A1L2U9, A2A884, A7Y7X5, B0X9H6, B0YDH7, B1WAZ8, B1WBU4, O35615, O77459
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| HNRNPU | “up-regulates quantity by stabilization” | ZFY | “post transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1517 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| Y:2935442:GTCGG:G | donor_gain | 1.0000 |
| Y:2935444:CGGG:C | donor_loss | 1.0000 |
| Y:2935445:GG:G | donor_gain | 1.0000 |
| Y:2935446:GG:G | donor_gain | 1.0000 |
| Y:2935447:G:C | donor_loss | 1.0000 |
| Y:2935447:G:GG | donor_gain | 1.0000 |
| Y:2935448:TGAGT:T | donor_loss | 1.0000 |
| Y:2961072:A:G | acceptor_gain | 1.0000 |
| Y:2961645:GT:G | donor_gain | 1.0000 |
| Y:2961647:G:GG | donor_gain | 1.0000 |
| Y:2975084:T:TA | acceptor_gain | 1.0000 |
| Y:2975090:TTCA:T | acceptor_loss | 1.0000 |
| Y:2975091:TCA:T | acceptor_loss | 1.0000 |
| Y:2975092:CAGT:C | acceptor_loss | 1.0000 |
| Y:2975093:A:AC | acceptor_loss | 1.0000 |
| Y:2975093:A:AG | acceptor_gain | 1.0000 |
| Y:2975093:AGT:A | acceptor_gain | 1.0000 |
| Y:2975093:AGTG:A | acceptor_gain | 1.0000 |
| Y:2975094:G:GA | acceptor_gain | 1.0000 |
| Y:2975094:GT:G | acceptor_gain | 1.0000 |
| Y:2975094:GTG:G | acceptor_gain | 1.0000 |
| Y:2975094:GTGG:G | acceptor_gain | 1.0000 |
| Y:2975094:GTGGA:G | acceptor_gain | 1.0000 |
| Y:2975245:G:C | donor_loss | 1.0000 |
| Y:2975245:G:GG | donor_gain | 1.0000 |
| Y:2975246:T:G | donor_loss | 1.0000 |
| Y:2975508:TAGGT:T | acceptor_loss | 1.0000 |
| Y:2975509:A:AG | acceptor_gain | 1.0000 |
| Y:2975509:A:T | acceptor_loss | 1.0000 |
| Y:2975510:G:GG | acceptor_gain | 1.0000 |
AlphaMissense
5423 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| Y:2978854:T:C | C423R | 1.000 |
| Y:2978855:G:A | C423Y | 1.000 |
| Y:2978856:C:G | C423W | 1.000 |
| Y:2978863:T:A | C426S | 1.000 |
| Y:2978863:T:C | C426R | 1.000 |
| Y:2978864:G:A | C426Y | 1.000 |
| Y:2978864:G:C | C426S | 1.000 |
| Y:2978865:T:G | C426W | 1.000 |
| Y:2978875:T:C | F430L | 1.000 |
| Y:2978876:T:C | F430S | 1.000 |
| Y:2978877:T:A | F430L | 1.000 |
| Y:2978877:T:G | F430L | 1.000 |
| Y:2978902:C:G | H439D | 1.000 |
| Y:2978904:C:A | H439Q | 1.000 |
| Y:2978904:C:G | H439Q | 1.000 |
| Y:2979136:T:C | C517R | 1.000 |
| Y:2979145:T:C | C520R | 1.000 |
| Y:2979146:G:A | C520Y | 1.000 |
| Y:2979147:T:G | C520W | 1.000 |
| Y:2979186:C:A | H533Q | 1.000 |
| Y:2979186:C:G | H533Q | 1.000 |
| Y:2979223:T:C | C546R | 1.000 |
| Y:2979224:G:A | C546Y | 1.000 |
| Y:2979225:T:G | C546W | 1.000 |
| Y:2979232:T:C | C549R | 1.000 |
| Y:2979244:T:C | F553L | 1.000 |
| Y:2979245:T:C | F553S | 1.000 |
| Y:2979246:C:A | F553L | 1.000 |
| Y:2979246:C:G | F553L | 1.000 |
| Y:2979263:T:C | L559P | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000144147 (Y:2935615 T>C), RS1000260605 (Y:2936577 C>G), RS1000333799 (Y:2939571 G>T), RS1000613335 (Y:2980551 G>A), RS1000767075 (Y:2978717 G>A), RS1001732720 (Y:2967583 G>T), RS1001879229 (Y:2970604 T>C), RS1002543248 (Y:2952322 C>T), RS1002847604 (Y:2968534 C>T), RS1003098404 (Y:2950580 G>A), RS1003545481 (Y:2962314 C>A), RS1004714498 (Y:2962860 G>A), RS1004776802 (Y:2964260 A>G), RS1006386662 (Y:2952716 G>A), RS1006825557 (Y:2973532 G>T)
Disease associations
OMIM: gene MIM:490000 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| Particulate Matter | increases methylation, increases abundance, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| bisphenol A | increases methylation | 1 |
| arsenite | decreases methylation, increases expression | 1 |
| sodium arsenite | affects methylation | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| abrine | increases expression | 1 |
| incobotulinumtoxinA | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Panobinostat | decreases expression | 1 |
| Air Pollutants, Occupational | affects expression | 1 |
| Amphotericin B | decreases expression | 1 |
| Vehicle Emissions | increases abundance, increases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Chromium | decreases expression | 1 |
| Clorgyline | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydroxyurea | increases expression | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Plant Oils | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Vanadates | increases expression | 1 |
| Vitamin E | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.